How has this study helped patients and
researchers?
This study helped researchers learn more about the safety of MEDI5083 and
durvalumab in participants with advanced solid tumors.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with MEDI5083 are not planned.
11 | Clinical Study Results